SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Calvert SAGE Fund – ‘NSAR-BT/A’ for 12/31/14 – ‘EX-99.77B ACCT LTTR’

On:  Monday, 10/26/15, at 12:49pm ET   ·   Effective:  10/26/15   ·   For:  12/31/14   ·   Accession #:  1438390-15-94   ·   File #:  811-22212

Previous ‘NSAR-BT’:  ‘NSAR-BT’ on 2/27/15 for 12/31/14   ·   Latest ‘NSAR-BT’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/26/15  Calvert SAGE Fund                 NSAR-BT/A  12/31/14    2:19K
          → Calvert Global Equity Income Fund Class A (CEIAX) — Class C (CEICX) — Class IClass Y (CEIYX)Calvert Global Value Fund Class A (CLVAX) — Class C (CLVCX) — Class IClass Y (CLVYX)

Amendment to Annual-Transition Report by an Investment Company   —   Form N-SAR   —   ICA’40
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: NSAR-BT/A   Amendment to 1231 Nsar Filing                         15     60K 
 2: EX-99.77B ACCT LTTR  Amendment to Auditor Letter                HTML      8K 


‘EX-99.77B ACCT LTTR’   —   Amendment to Auditor Letter


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <> 
  CSF  

KPMG LLP

1601 Market Street

Philadelphia, PA 19103-2499

Report of Independent Registered Public Accounting Firm

The Board of Trustees of Calvert SAGE Fund:

In planning and performing our audits of the financial statements of Calvert Large Cap Value Fund and Calvert Equity Income Fund, each a series of Calvert SAGE Fund (hereafter referred to as the "Funds"), as of and for the period ended December 31, 2014, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered the Funds' internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-SAR, but not for the purpose of expressing an opinion on the effectiveness of the Funds' internal control over financial reporting. Accordingly, we express no such opinion.

Management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds' annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Funds' internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in the Funds' internal control over financial reporting and its operation, including controls over safeguarding securities that we consider to be a material weakness as defined above as of December 31, 2014.

This report is intended solely for the information and use of management and the Board of Trustees of the Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

 

/s/ KPMG LLP

February 24, 2015

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘NSAR-BT/A’ Filing    Date    Other Filings
Filed on / Effective on:10/26/15CORRESP,  NSAR-B/A
2/24/15
For Period end:12/31/1424F-2NT,  N-CSR,  NSAR-BT
 List all Filings 
Top
Filing Submission 0001438390-15-000094   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 6:04:06.1am ET